네이처셀

007390KOSDAQSector: Pharma & Biotech

₩24,750▲ 9.03%Market cap ₩1.59TAs of Jul 21, 2026 close · updated once daily

Grade C41.7 ptsTop 69% of 2,523 stocks

Financial strength

59.4

Growth momentum

28.5

Price attractiveness

30.9

As of Jul 21, 2026 close · This grade is not a buy/sell recommendation — it is information mechanically scored from public data using a fixed formula.

Financial strength

59.4

How much debt does it carry relative to equity?

Debt-to-equity ratio

18.6%

✓ Above median · Top 20.9% in sector

Sector median 51.5%

Can it cover what's due within a year?

Current ratio

331.8%

✓ Above median · Top 32.3% in sector

Sector median 191.3%

How much of revenue becomes profit?

Operating margin

-17.6%

✗ Below median · Top 59.1% in sector

Sector median -2.3%

How much did it earn on its own capital?

ROE (return on equity)

-4.5%

✗ Below median · Top 50.2% in sector

Sector median -4.5%

Source filing: annual report (consolidated) — view original ↗

Growth momentum

28.5

How much did revenue grow in a year?

Revenue growth (YoY)

-35.9%

✗ Below median · Top 93.8% in sector

Sector median 6.4%

Has it grown steadily over three years?

Revenue 3-year CAGR

-1.3%

✗ Below median · Top 70.6% in sector

Sector median 4.9%

Did core profits grow in a year?

Operating income change (YoY)

-710.2%

✗ Below median · Top 97.1% in sector

Sector median 3.6%

Are core profits higher than three years ago?

Operating income change (3Y)

61.6%

✓ Above median · Top 24.5% in sector

Sector median 3.5%

Source filing: annual report (consolidated) — view original ↗

Price attractiveness

30.9

Is the price expensive relative to earnings?

P/E (price-to-earnings)

Loss-making (P/E not computable)

✓ Above median · Top 44.5% in sector

Sector median P/E of profitable peers 14.4x · 57% loss-making

Is the price expensive relative to book value?

P/B (price-to-book)

25.32x

✗ Below median · Top 93.7% in sector

Sector median 1.39x

Valuation uses the Jul 21, 2026 close and market cap

Grade distribution of 248 stocks in Pharma & Biotech

S1A52B66C51D61F15